# Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer

> **NCT02545010** · PHASE1 · UNKNOWN · sponsor: **National University Hospital, Singapore** · enrollment: 24 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Paclitaxel
- **RADIATION:** LDWART (Low Dose Whole Abdominal Radiation Therapy)

## Key facts

- **NCT ID:** NCT02545010
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2017-08
- **Final completion:** 2018-08
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2016-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02545010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02545010, "Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02545010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*